Search Press releases Keywords From To 19 Feb 2016 U.S. FDA approves UCB’s new epilepsy treatment, BRIVIACT®, for patients with partial-onset seizures Read More 8 Feb 2016 UCB and Baylor College of Medicine launch strategic alliance in neurodegeneration Read More 19 Jan 2016 UCB’s new epilepsy drug BRIVIACT® receives EU approval Read More 14 Jan 2016 UCB’s Executive Committee welcomes a new member Read More 8 Jan 2016 Transparency notification Read More 18 Dec 2015 Transparency notification Read More Pagination First page Previous page Previous … Page 92 Page 93 Page 94 Page 95 Current page 96 Page 97 Page 98 Page 99 Page 100 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
